National Blood Authority partners with NPS MedicineWise to improve the use of immunoglobulin

Today, NPS MedicineWise announced a partnership with the National Blood Authority to deliver and evaluate a national, multi-faceted, evidence-based program to support best-practice prescribing of immunoglobulins.

The program is funded under a grant awarded by the Australian Government’s Value in Prescribing program - Immunoglobulin Products stream and will see NPS MedicineWise working with the National Blood Authority and a range of stakeholders to develop and deliver educational resources, tools and interventions to support clinicians in optimising the use of precious immunoglobulin products, as well as to educate consumers on the role of these products.

For more information on the Program, visit the NPS MedicineWise website.